Effects of Stress-reducing Aromatherapy
Physiologic and Expectancy Effects of Stress-reducing Aroma in Older Adults
1 other identifier
interventional
92
1 country
1
Brief Summary
The study purpose is to evaluate efficacy of stress-reducing aromatherapy and learn about how aromatherapy works.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Dec 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 2, 2011
CompletedFirst Posted
Study publicly available on registry
March 3, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedResults Posted
Study results publicly available
August 19, 2019
CompletedAugust 19, 2019
July 1, 2019
2 years
March 2, 2011
December 28, 2018
July 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent of Baseline Level of Salivary Cortisol
Percent of baseline level of salivary cortisol (values greater than baseline indicate increased stress)
assessed at baseline (60 min prior to aroma exposure and stress), stress battery (30 min after aroma exposure and during stress), post-stress (60 min after completing stress battery)
Secondary Outcomes (2)
Electroencephalography (EEG) Frontal Asymmetry
assessed at baseline (60 min prior to aroma exposure and stress), at the onset of aromatherapy exposure, stress battery (30 min after aroma exposure and during stress), post-stress (60 min after completing stress battery)
Cognitive Performance: Percent Change From Baseline in Digit Span Backward Task Score
Baseline (60 min prior to aroma exposure and stress), post-stress (60 min after completing stress battery)
Study Arms (3)
stress reducing aroma
EXPERIMENTALaroma with reported stress reducing effects
Placebo aroma 1
PLACEBO COMPARATORPlacebo aroma 2
PLACEBO COMPARATORInterventions
Comparison of known stress reducing aroma to placebo aromas without stress-reducing effects
Eligibility Criteria
You may qualify if:
- in good physical and cognitive health
- reporting moderate level of stress
- able to perceive aromas
- able to understand and follow study instructions
You may not qualify if:
- taking medications affecting central nervous system (CNS) function or physiologic measures (e.g. steroids or neuroleptics)
- reporting smell sensitivities or allergies
- smoking presently or in the past less than one year prior to enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health & Science University
Portland, Oregon, 97239, United States
Related Publications (2)
Chamine I, Oken BS. Aroma Effects on Physiologic and Cognitive Function Following Acute Stress: A Mechanism Investigation. J Altern Complement Med. 2016 Sep;22(9):713-21. doi: 10.1089/acm.2015.0349. Epub 2016 Jun 29.
PMID: 27355279RESULTChamine I, Oken BS. Expectancy of stress-reducing aromatherapy effect and performance on a stress-sensitive cognitive task. Evid Based Complement Alternat Med. 2015;2015:419812. doi: 10.1155/2015/419812. Epub 2015 Jan 31.
PMID: 25802539RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Sample included well-educated people over 50 interested in aromatherapy (mostly female). The essential oil and placebo aromas preparations were study-specific.The results are most relevant to the doses and preparations of the aroma stimuli we used.
Results Point of Contact
- Title
- Irina Chamine
- Organization
- Oregon Health & Science University
Study Officials
- PRINCIPAL INVESTIGATOR
Barry S Oken, MD
Oregon Health and Science University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 2, 2011
First Posted
March 3, 2011
Study Start
December 1, 2010
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
August 19, 2019
Results First Posted
August 19, 2019
Record last verified: 2019-07